Insider Transactions in Q4 2020 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.65%
|
$0
$0.35 P/Share
|
|
Dec 09
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+3.4%
|
$26,000
$13.07 P/Share
|
|
Dec 08
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+3.52%
|
$26,000
$13.24 P/Share
|
|
Nov 23
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
929
+1.73%
|
$12,077
$13.67 P/Share
|
|
Nov 20
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
571
+1.09%
|
$7,423
$13.69 P/Share
|
|
Nov 19
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.96%
|
$6,500
$13.5 P/Share
|
|
Nov 11
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+4.69%
|
$32,500
$13.75 P/Share
|
|
Nov 10
2020
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+3.97%
|
$26,000
$13.86 P/Share
|
|
Oct 05
2020
|
Eric Dobmeier President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
46,337
+50.0%
|
-
|
|
Oct 05
2020
|
Tom Frohlich Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
153,398
+50.0%
|
-
|
|
Oct 05
2020
|
Davis Jerel Director |
BUY
Grant, award, or other acquisition
|
Indirect |
7,888,369
+50.0%
|
-
|
|
Oct 05
2020
|
Davis Jerel Director |
BUY
Grant, award, or other acquisition
|
Direct |
730,470
+50.0%
|
-
|
|
Oct 05
2020
|
Srinivas Akkaraju Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,168,388
+50.0%
|
-
|